Biological evaluation of an antibiotic DC-81-indole conjugate agent in human melanoma cell lines
- PMID: 12693720
- PMCID: PMC11917818
- DOI: 10.1016/S1607-551X(09)70441-3
Biological evaluation of an antibiotic DC-81-indole conjugate agent in human melanoma cell lines
Abstract
Pyrrolo[2, 1-c][1, 4]benzodiazepines (PBDs) are potent inhibitors of nucleic acid synthesis because of their ability to recognize and bind to specific sequences of DNA and form a labile covalent adduct. DC-81, an antitumor antibiotic produced by Streptomyces species, is a PBD. We combined DC-81 and an indole carboxylate moiety to synthesize a hybrid designed to have much higher sequence selectivity in DNA interactivity. In this paper, the cytotoxic potency of the hybrid in human melanoma cell lines was studied. XTT assay demonstrated that the DC-81-indole conjugate possessed cytotoxicity against human melanoma cell lines.
References
-
- Hurley LH. Pyrrolo(1,4)benzodiazepine antitumor antibiotics. Comparative aspects of anthramycin, tomaymycin and sibiromycin. J Antibiot. 1977; 30: 349–370. - PubMed
-
- Kohn KW. Anthramycin. In Corcoran JW, Hahn FE, eds. Mechanism of Action of Antimicrobial and Antitumor Agents. New York: Springer‐Verlag. 1975, 3–11.
-
- Petrusek RL, Uhlenhopp EL, Duteau N, Hurley LH. Reaction of anthramycin with DNA. J Biol Chem. 1982; 257: 6207–6216. - PubMed
-
- Hurley LH, Petrusek RL. Proposed structure of the anthramycin‐DNA adduct. Nature. 1979; 282: 529–531. - PubMed
-
- Cheatham S, Kook A, Hurley LH, et al. One‐ and two‐dimensional 1, H NMR, fluorescence, and molecular modeling studies on the tomaymycin‐d(ATGCAT)2 adduct. Evidence for two covalent adducts with opposite orientations and stereochemistries at the covalent linkage site. J Med Chem. 1988; 31: 583–590. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
